Skip to main content
. 2017 Feb 5;8(27):44842–44850. doi: 10.18632/oncotarget.15107

Figure 3. Comparison of the treatment outcomes between Pre-S RT and Pre-S CRT groups ristricted to primary larynx-hypopharynx carcinoma only.

Figure 3